Xingping Zhou

State Key Laboratory For Diagnosis And Treatment Of Infectious Diseases
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Performance of the China-CLIF framework in acute-on-chronic liver failure: a multicohort study across all aetiologies.

Performance of the China-CLIF framework in acute-on-chronic liver failure: a multicohort study across all aetiologies.

Journal: Gut

Published: April 21, 2025

Integrating prior decompensation into ACLF definition to enhance clinical management.

Integrating prior decompensation into ACLF definition to enhance clinical management.

Journal: Hepatology international

Published: December 18, 2024

Single-cell multimodal analysis reveals the dynamic immunopathogenesis of HBV-ACLF progression.

Single-cell multimodal analysis reveals the dynamic immunopathogenesis of HBV-ACLF progression.

Journal: Gut

Published: July 09, 2024

SEMA6B induces macrophage-mediated inflammation and hepatocyte apoptosis in hepatitis B virus-related acute-on-chronic liver failure.

SEMA6B induces macrophage-mediated inflammation and hepatocyte apoptosis in hepatitis B virus-related acute-on-chronic liver failure.

Journal: Theranostics

Published: April 05, 2024

Thrombospondin 1 enhances systemic inflammation and disease severity in acute-on-chronic liver failure.

Thrombospondin 1 enhances systemic inflammation and disease severity in acute-on-chronic liver failure.

Journal: BMC medicine

Published: October 31, 2023

Plasma thrombomodulin as a candidate biomarker for the diagnosis and prognosis of HBV-related acute-on-chronic liver failure.

Plasma thrombomodulin as a candidate biomarker for the diagnosis and prognosis of HBV-related acute-on-chronic liver failure.

Journal: Infection and drug resistance

Published: September 27, 2023

Plasma MERTK Is a Promising Biomarker for the Diagnosis and Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.

Plasma MERTK Is a Promising Biomarker for the Diagnosis and Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.

Journal: The Journal of infectious diseases

Published: September 01, 2023

Orthotopic Transplantation of Functional Bioengineered Livers in Rats.

Orthotopic Transplantation of Functional Bioengineered Livers in Rats.

Journal: ACS biomaterials science & engineering

Published: March 13, 2023

Generation and metabolomic characterization of functional ductal organoids with biliary tree networks in decellularized liver scaffolds.

Generation and metabolomic characterization of functional ductal organoids with biliary tree networks in decellularized liver scaffolds.

Journal: Bioactive materials

Published: December 16, 2022

Transcriptomics unveils immune metabolic disruption and a novel biomarker of mortality in patients with HBV-related acute-on-chronic liver failure.

Transcriptomics unveils immune metabolic disruption and a novel biomarker of mortality in patients with HBV-related acute-on-chronic liver failure.

Journal: JHEP reports : innovation in hepatology

Published: November 20, 2022

Predicting the survival benefit of liver transplantation in HBV-related acute-on-chronic liver failure: an observational cohort study.

Predicting the survival benefit of liver transplantation in HBV-related acute-on-chronic liver failure: an observational cohort study.

Journal: The Lancet regional health. Western Pacific

Published: July 25, 2022

Predicting the Onset of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.

Predicting the Onset of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: December 20, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026